Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225234 · ClinicalTrials.gov registry record · NA
Sustaining the Reach of a Scalable Weight Loss Intervention Through Financial Incentives
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT04225234: Clinical Trial NA study, sponsored by University of Nebraska.
NCT04225234 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 119 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225234, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
This study seeks to assess how different incentive strategies may reduce the initial attrition gap when implementing weight management in a primary care clinic predominantly serving African American patients. This will be done through an innovative research-practice partnership involving primary care, research expertise, and a small business. Participants will be randomly assigned to one of four financial incentive conditions respectively tied to: weight loss, weigh-ins, weigh-ins and weight-loss, and incentive choice. Participants will be followed for 3 and 6 months to assess program reach, sustaining the reach after initial weigh-in, and weight loss outcomes based on records on participant enrollment and subsequent weigh-ins automatically collected through a kiosk at the clinic.
Primary Outcome
Percentage of participants returning to weigh-in 3, 6, and 12 months after initial program registration
Interventions
- OTHER Financial incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Why NCT04225234 stopped before completion
NCT04225234 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Financial incentives is the first listed.
NCT04225234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04225234 about?
NCT04225234 is a clinical study titled "Sustaining the Reach of a Scalable Weight Loss Intervention Through Financial Incentives". This study seeks to assess how different incentive strategies may reduce the initial attrition gap when implementing weight management in a primary care clinic predominantly serving African American patients. This will be done through an innovative research-practice partnership involving primary car...
What is the current status of trial NCT04225234?
This trial is currently terminated. It is a NA study. The enrollment target is 119 participants. The study started on 2019-08-20. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT04225234?
The interventions under investigation include: Financial incentives (OTHER).
Who is sponsoring clinical trial NCT04225234?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04225234's enrollment target sits among peer trials
119 803rd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI